A Stanford conference of COVID contrarians and Long COVID skeptics featuring President Levin is reverberating all the way to ...

Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine has generated the production of antibodies, new research from the University ...

Wide areas of the pharmaceutical industry are ripe for enhancement, as examples from the industry’s top innovators reflect.

After over a decade of leading the MRC-University of Glasgow Centre for Virus Research (CVR), Professor Massimo Palmarini is stepping down as Dir ...

NanoViricides announces its antiviral drug, NV-387 can fight bird flu pandemic; H5N1 virus will not be able to escape even as it changes in the field: Shelton, Connecticut Thursda ...

Some public health data targeted by Trump’s executive orders has been restored, but what’s changed and how will that affect health policy?

A new study from researchers at Weill Cornell Medicine-Qatar (WCM-Q) reveals how the SARS-CoV-2 virus evolved from initially ...

Certain antiviral and mAb therapies were shown to lower mortality and hospitalization rates in those infected with SARS-CoV-2 Omicron variants.

A North-South partnership between the Genomic Surveillance Unit at the Wellcome Sanger Institute in Cambridge and the Centre ...

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

SK bioscience completes WHO project as sole private participant for SARS standards SK bioscience achieves notable milestone ...